Our Innovation Legacy:
The Patent Portfolio
At NeuroEM, we stand at the forefront of pioneering research into Transcranial Electromagnetic Treatment (TEMT), a revolutionary approach with the potential to transform the therapeutic landscape for neurodegenerative diseases. Our dedication extends beyond research; it is our mission to bridge the gap between groundbreaking scientific discoveries and real-world applications that can profoundly impact lives.
Our patent portfolio is a testament to this commitment. It is not just a collection of documents; it is a reflection of our journey, our intellectual rigor, and our vision for the future of medicine. Each patent represents a stepping stone towards unlocking the full therapeutic potential of TEMT, underpinning our strategy to safeguard and leverage our innovations for maximum societal benefit.
Through this portfolio, we invite investors, collaborators, and the scientific community to explore the depth and breadth of our research endeavors as we pave pathways for treating conditions once thought untreatable.
Our patent portfolio is open for you to understand the scope of our work, the potential impact of our technology, and the investment opportunities that lie ahead. Join us on this exciting journey as we push the boundaries of science and technology to create a healthier, brighter future for all.
Welcome to the heart of innovation at NeuroEM Therapeutics.
US Patents - Owned
Electromagnetic Treatment of Brain and Body Disorders
Disclosed are devices, methods, and systems for helping to prevent (or preventing) or treat brain and/or body disorders. Embodiments of the invention have utility for enhancing cognitive function during aging. The invention utilizes electromagnetic stimulation (EMS) that can provide a range of EMS parameters and modalities. The EMS may be utilized in conjunction with physiologic sensors that can provide feedback for possible EMS modifications.
US 10,765,879 B2
Systems for Controlling Power to Differently Loaded Antenna Arrays
In one example in accordance with the present disclosure, an antenna system is described. The antenna system includes an array of antennas. Each antenna emits electromagnetic waves and is presented with a load that is different from other antennas in the array. The antenna system also includes a control system. The control system includes a single transmitter to sequentially drive antenna sets, a switching device to select, for each activation period in an activation sequence, an antenna set to be driven, and a controller. The controller determines an actual power output of each antenna and generates an adjusted control signal for the single transmitter such that the output of each antenna is controlled to match a target power for that antenna, regardless of a load for the antenna.
US 11,752,356 B2
Systems for Sensing Proper Emitter Array Placement
In one example in accordance with the present disclosure, an emitter system is described. The emitter system includes an array of emitters. Each emitter emits waves towards a target surface. The emitter system also includes a control system. The control system includes a sensing system to determine whether emitters in the array are properly positioned relative to the target surface. A controller of the control system adjusts emitter sets of the array of emitters based on an output of the sensing system.
US 11,813,472 B2
Immunoregulation, Brain Detoxification, and Cognitive Protection by Electromagnetic Treatment
In one example in accordance with the present disclosure a method of normalizing cytokine levels in a blood stream of a subject is described. According to the method, an array of electromagnetic emitters is positioned proximal to the subject. An electromagnetic wave generator generates electromagnetic fields having a predetermined frequency. Cytokine levels are normalized in the blood stream of the subject by applying the electromagnetic fields to the subject through the electromagnetic emitters.
US 11,759,650 B2
Transcranial Electromagnetic Treatment
In one example in accordance with the present disclosure a method is described. According to the method, an emitter of a transcranial electromagnetic treatment (TEMT) system is positioned at a location relative to a head of a patient such that the emitter emits an electromagnetic frequency signal toward the head of the patient. The emitter is activated to apply TEMT to the patient to treat amyloid oligomers. In some examples, the TEMT has a frequency between 1 MHz and 430 THz.
US 11,794,028 B2
Treatment of Primary and Metastatic Brain Cancers by Transcranial Electromagnetic Treatment
The present disclosure describes such methods to therapeutically induce regression and/or elimination of primary and metastatic brain cancers through Transcranial Electromagnetic Treatment (TEMT). The methods involve 1) enhancement of brain meningeal lymph flow to increase immune trafficking between the brain cancer and cervical lymph nodes, 2) rebalancing of immune or non-immune signaling within the brain, particularly from the brain tumor to the lymphatic system, and/or 3) direct attack on cells within and around the brain tumor itself.
US 11,911,629 B2
US Patents - Exclusively Licensed
Skull-focused RF-based Stimulation Apparatus, System and Method for Treating Patients with Alzheimer's Disease or Other Dementia
The portable, wearable, proximal Alzheimer's disease treatment invention is based upon creating an RF field of particular frequencies and intensities that are applied to the patient's head. To accomplish the aforementioned disease treatment functionality, a system was invented comprising a network of antennas connected to an RF generator via a feedline connector. The invention also provides methods for using measurements to monitor and manage the effectiveness of an ongoing disease treatment regimen, and databases which contain information about measurements, variables, and their relationships to clinical outcome.
US 9,037,268 B2
Prevention and Treatment of Alzheimer’s Disease Through Electromagnetic Field Exposure
The invention includes a method of treating and preventing a neurological disorder, such as Alzheimer's Disease, in a subject in need thereof by positioning an electromagnetic field emitting source proximal to the subject and exposing the subject to an electromagnetic field having a predetermined frequency for a predetermined absorption period. Preferably, each individual treatment (comprising exposure to the predetermined frequency for the predetermined absorption period) is continued at a predetermined schedule (preferably daily) for a predetermined treatment period.
US 9,238,149 B2
Prevention and Treatment of Brain Diseases and Disorders Related to Abnormal Protein Aggregation Through Electromagnetic Field Treatment
A method of treating and preventing a neurological disorder, such as Alzheimer's disease, in a subject in need thereof by positioning an electromagnetic field emitting source proximal to the subject and exposing the subject to an electromagnetic field having a predetermined frequency (preferably ≈300-3,000 MHz) for a predetermined absorption period (preferably greater than ≈3 days).
US 10,149,982 B2
US Patents - Pending
Brain Immunoregulation and Increased Human Life Span Through Transcranial Electromagnetic Treatment
The present disclosure describes a method of regulating (re-balancing) the brain's immune system to decrease occurrence and/or severity of age-related diseases and increase life span. According to the method, an array of electromagnetic emitters are positioned proximal to the subject. An electromagnetic wave generator generates electromagnetic waves at a predetermined set of parameters.
US 20220040492 A1
Increased Human Life Span Through Transcranial Electromagnetic Treatment
The present disclosure describes methods and devices for increasing human life span (longevity) via electromagnetic treatment. An array of electromagnetic emitters are positioned proximal to a subject. An electromagnetic wave generator generates electromagnetic fields having a predetermined set of parameters. Life span is increased by applying the electromagnetic waves to the subject through the electromagnetic emitters
US 20230050752 A1